Triple-Negative Breast Cancer Panel 3
Triple-Negative Breast Cancer Panel 3
规格:
货期:
编号:TS147857
品牌:Testobio
| 产品名称： | Triple-Negative Breast Cancer Panel 3 |
|---|---|
| 商品货号： | TS147857 |
| Organism： | Homo sapiens, human |
| Components： | HCC1599, ATCC CRL-2331
HCC1937, ATCC CRL-2336
HCC1143, ATCC CRL-2321
MDA-MB-468, ATCC HTB-132
HCC38, ATCC CRL-2314
HCC70, ATCC CRL-2315
HCC1806, ATCC CRL-2335
HCC1187, ATCC CRL-2322
DU4475, ATCC HTB-123
BT-549, ATCC HTB-122
Hs 578T, ATCC HTB-126
MDA-MB-231, ATCC HTB-26
MDA-MB-436, ATCC HTB-130
MDA-MB-157, ATCC HTB-24
MDA-MB-453, ATCC HTB-131
BT-20, ATCC HTB-19
HCC1395, ATCC CRL-2324 |
| Applications： | Biological understanding of top genetic alterations across tumor types Validation and characterization of potential cancer driver genes Functional profiling and molecular profiling of subtype-specific cancer cell lines Testing small molecules or biologics for cancer drug development |
| Type Strain： | no |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Comments： | A panel of 17 triple-negative breast tumor cell lines sharing a mesenchymal-like or luminal morphology. See J Clinical Inv (2011) 121(7):2750-2767 for more information.
Ref   Lehmann BD, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J. Clin. Invest. 121: 2750-2767, 2011. PubMed: 21633166 |
| Product Format： | frozen |
| Storage Conditions： | LN vapor (less than -130°C) only |
首页 >
产品中心
>
微生物培养
>
菌株
>
null
>
Triple-Negative Breast Cancer Panel 3
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Triple-Negative Breast Cancer Panel 3 |
|---|---|
| 商品货号： | TS147857 |
| Organism： | Homo sapiens, human |
| Components： | HCC1599, ATCC CRL-2331
HCC1937, ATCC CRL-2336
HCC1143, ATCC CRL-2321
MDA-MB-468, ATCC HTB-132
HCC38, ATCC CRL-2314
HCC70, ATCC CRL-2315
HCC1806, ATCC CRL-2335
HCC1187, ATCC CRL-2322
DU4475, ATCC HTB-123
BT-549, ATCC HTB-122
Hs 578T, ATCC HTB-126
MDA-MB-231, ATCC HTB-26
MDA-MB-436, ATCC HTB-130
MDA-MB-157, ATCC HTB-24
MDA-MB-453, ATCC HTB-131
BT-20, ATCC HTB-19
HCC1395, ATCC CRL-2324 |
| Applications： | Biological understanding of top genetic alterations across tumor types Validation and characterization of potential cancer driver genes Functional profiling and molecular profiling of subtype-specific cancer cell lines Testing small molecules or biologics for cancer drug development |
| Type Strain： | no |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Comments： | A panel of 17 triple-negative breast tumor cell lines sharing a mesenchymal-like or luminal morphology. See J Clinical Inv (2011) 121(7):2750-2767 for more information.
Ref Lehmann BD, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J. Clin. Invest. 121: 2750-2767, 2011. PubMed: 21633166 |
| Product Format： | frozen |
| Storage Conditions： | LN vapor (less than -130°C) only |
